Nordea Investment Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.07M Buy
12,228
+8
+0.1% +$1.64K ﹤0.01% 743
2025
Q4
$3.17M Buy
12,220
+673
+6% +$176K ﹤0.01% 686
2025
Q3
$2.98M Buy
11,547
+1,325
+13% +$348K ﹤0.01% 689
2025
Q2
$2.48M Buy
10,222
+507
+5% +$126K ﹤0.01% 694
2025
Q1
$2.55M Buy
9,715
+36
+0.4% +$9.74K ﹤0.01% 660
2024
Q4
$2.49M Buy
9,679
+602
+7% +$161K ﹤0.01% 650
2024
Q3
$2.94M Sell
9,077
-28,583
-76% -$10.2M ﹤0.01% 625
2024
Q2
$14.1M Buy
37,660
+107
+0.3% +$36.1K 0.02% 361
2024
Q1
$13.1M Sell
37,553
-562
-1% -$213K 0.02% 383
2023
Q4
$17.5M Sell
38,115
-158
-0.4% -$77.9K 0.02% 340
2023
Q3
$18.8M Sell
38,273
-5,460
-12% -$2.57M 0.03% 307
2023
Q2
$19.3M Buy
43,733
+29,551
+208% +$14.9M 0.03% 315
2023
Q1
$6.93M Buy
14,182
+195
+1% +$96.4K 0.01% 451
2022
Q4
$7.12M Sell
13,987
-360
-3% -$189K 0.01% 442
2022
Q3
$7.08M Buy
14,347
+6,137
+75% +$2.99M 0.01% 431
2022
Q2
$3.86M Buy
8,210
+532
+7% +$237K 0.01% 591
2022
Q1
$3.39M Sell
7,678
-924
-11% -$387K ﹤0.01% 644
2021
Q4
$4.01M Sell
8,602
-21,145
-71% -$9.36M ﹤0.01% 621
2021
Q3
$11.8M Buy
29,747
+23
+0.1% +$9.76K 0.02% 371
2021
Q2
$13.2M Buy
29,724
+1,040
+4% +$454K 0.02% 352
2021
Q1
$12.1M Buy
28,684
+122
+0.4% +$48.7K 0.02% 350
2020
Q4
$11.7M Buy
28,562
+9,262
+48% +$3.85M 0.02% 348
2020
Q3
$7.87M Sell
19,300
-17,010
-47% -$6.84M 0.01% 363
2020
Q2
$13.8M Buy
36,310
+23,250
+178% +$8.7M 0.01% 368
2020
Q1
$4M Buy
13,060
+230
+2% +$77.6K 0.01% 484
2019
Q4
$4.7M Sell
12,830
-90
-0.7% -$28.5K 0.01% 554
2019
Q3
$3.29M Sell
12,920
-83,130
-87% -$23.3M 0.01% 653
2019
Q2
$25.5M Buy
96,050
+41,208
+75% +$10.5M 0.06% 251
2019
Q1
$14.6M Buy
54,842
+5,156
+10% +$1.49M 0.03% 326
2018
Q4
$14.2M Buy
49,686
+27,347
+122% +$8.67M 0.03% 318
2018
Q3
$7.56M Buy
22,339
+3,359
+18% +$1.09M 0.02% 454
2018
Q2
$5.65M Buy
18,980
+12,086
+175% +$3.54M 0.01% 427
2018
Q1
$1.85M Sell
6,894
-189
-3% -$51.2K ﹤0.01% 766
2017
Q4
$1.76M Sell
7,083
-366
-5% -$90.4K ﹤0.01% 733
2017
Q3
$1.81M Buy
7,449
+111
+2% +$27.2K ﹤0.01% 726
2017
Q2
$1.77M Buy
7,338
+74
+1% +$16.8K ﹤0.01% 717
2017
Q1
$1.5M Sell
7,264
-457
-6% -$94.5K ﹤0.01% 692
2016
Q4
$1.57M Buy
7,721
+221
+3% +$42.1K ﹤0.01% 572
2016
Q3
$1.33M Buy
7,500
+375
+5% +$65.1K ﹤0.01% 553
2016
Q2
$1.28M Sell
7,125
-121
-2% -$21.5K ﹤0.01% 500
2016
Q1
$1.33M Buy
7,246
+1,970
+37% +$342K ﹤0.01% 495
2015
Q4
$942K Buy
5,276
+130
+3% +$22.8K ﹤0.01% 550
2015
Q3
$921K Buy
5,146
+200
+4% +$37K ﹤0.01% 461
2015
Q2
$946K Sell
4,946
-208
-4% -$38.6K ﹤0.01% 461
2015
Q1
$918K Buy
5,154
+692
+16% +$110K ﹤0.01% 472
2014
Q4
$641K Sell
4,462
-352
-7% -$48.1K ﹤0.01% 551
2014
Q3
$627K Sell
4,814
-15,485
-76% -$1.97M ﹤0.01% 565
2014
Q2
$2.59M Buy
20,299
+768
+4% +$91K 0.01% 382
2014
Q1
$2.2M Hold
19,531
0.01% 408
2013
Q4
$2.02M Buy
19,531
+521
+3% +$51K 0.01% 429
2013
Q3
$1.77M Hold
19,010
0.01% 462
2013
Q2
$1.6M Buy
+19,010
New +$1.5M 0.01% 477

Other funds holding HUM

Nordea Investment Management's HUM Position: Q1 2026 in Review

Nordea Investment Management increased its Humana (HUM) stake by 0.07% in Q1 2026, buying an estimated $1.64K and bringing the position to 12,228 shares worth $2.07M. The position accounts for ﹤0.01% of the portfolio, ranked #743.

Nordea Investment Management first reported a position in HUM in Q2 2013 and has held it in 52 quarters since. The position peaked at $25.5M in Q2 2019. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Nordea Investment Management held 12,228 shares of Humana worth $2.07M as of Q1 2026.
  • Nordea Investment Management bought 8 Humana shares in Q1 2026, an estimated $1.64K.
  • Humana made up ﹤0.01% of Nordea Investment Management's portfolio in Q1 2026, its #743 holding.
  • Nordea Investment Management first reported a position in Humana in Q2 2013 and has held it in 52 quarters since.
  • Nordea Investment Management's Humana position peaked at $25.5M in Q2 2019.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Nordea Investment Management's 13F filing for Q1 2026, filed 13 May 2026.